Cell injection aims to slow vision loss in rare eye disease

NCT ID NCT06912633

Ongoing Disease control Sponsor: jCyte, Inc Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 2 times

Summary

This study tests the safety of a single injection of jCell (retinal progenitor cells) into the eye for people with retinitis pigmentosa, a genetic condition that causes vision loss. Sixty adults will receive either the active treatment or a sham injection, and researchers will monitor side effects and any changes in eyesight over six months. The goal is to see if this approach can help control the disease and preserve vision.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

retinitis pigmentosa

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RETINITIS PIGMENTOSA

Contacts and locations

Locations

Associated Retina Consultants

Phoenix, Arizona, 85020, United States
California Retina Consultants

Bakersfield, California, 93309, United States
Gavin Herbert Eye Institute, UC Irvine

Irvine, California, 92697, United States
Illinois Retina Associates

Oak Park, Illinois, 60304, United States
Long Island Vitreoretinal Consultants

Westbury, New York, 11590, United States
NJRetina

Teaneck, New Jersey, 07666, United States
Retina Consultants Medical Group

Sacramento, California, 95825, United States
Retina Consultants of Texas: Bellaire Retina Center

Bellaire, Texas, 77401, United States
Retina Consultants of Texas: San Antonio

San Antonio, Texas, 78240, United States
Retina-Vitreous Associates Medical Group

Beverly Hills, California, 90074, United States
The Retina Group of Washington

Fairfax, Virginia, 22031, United States
Vitreo Retinal Associates

Gainesville, Florida, 32607, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.